Lin Kai-Liang, Lin Wei-Yu, Wang Yen-Po, Luo Jiing-Chyuan, Hou Ming-Chih, Lang Hui-Chu, Lu Ching-Liang
Endoscopy Center for Diagnosis and Treatment, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
J Chin Med Assoc. 2025 May 1;88(5):383-388. doi: 10.1097/JCMA.0000000000001214. Epub 2025 Feb 7.
Achalasia is a rare disease of gastrointestinal motility characterized by impaired esophageal peristalsis and reduced esophageal sphincter relaxation. However, data on its epidemiology and outcomes in Taiwan are limited. This study aimed to assess the incidence, characteristics, and clinical management of achalasia in Taiwan.
Patients who were newly diagnosed with achalasia between 2001 and 2013 were recruited from the Taiwan National Health Insurance Research Database. The study obtained data on the age, sex, urbanization, socioeconomic status, area of residence, diagnostic methods, and interventional management of the patients. Incidence, diagnostic modalities, treatment methods, malignancy, and mortality outcomes were analyzed.
In total, 206 new achalasia cases were identified. The mean annual incidence in Taiwan was 1.64 (95% confidence interval, 1.22-2.05) per 100 000 persons. The mean age of the patients at diagnosis was 51.8 years. The age-specific incidence of achalasia peaked in patients aged between 70 and 80 years and above 80 years. For achalasia diagnosis, endoscopy, computed tomography (CT), barium studies, and manometry were performed in 123 (59.71%), 97 (47.09%), 49 (23.79%), and 11 patients (5.34 %), respectively. During long-term follow-up, seven patients (3.39%) developed esophageal cancer, and 39 patients (18.93%) died. The median survival was 10.65 years after achalasia diagnosis, with a 10-year survival rate of 76.22%.
This is the first population-based epidemiological study on achalasia in Taiwan, revealing the incidence of achalasia before the era of high-resolution manometry. Clinicians should be vigilant about the development of esophageal cancer and mortality during long-term follow-ups. There is also room to enhance the utilization of various diagnostic tools for achalasia.
贲门失弛缓症是一种罕见的胃肠动力疾病,其特征为食管蠕动受损和食管括约肌松弛减弱。然而,台湾地区关于其流行病学和结局的数据有限。本研究旨在评估台湾地区贲门失弛缓症的发病率、特征及临床管理情况。
从台湾全民健康保险研究数据库中招募2001年至2013年间新诊断为贲门失弛缓症的患者。该研究获取了患者的年龄、性别、城市化程度、社会经济状况、居住地区、诊断方法及介入治疗管理等数据。对发病率、诊断方式、治疗方法、恶性肿瘤及死亡率结局进行了分析。
共识别出206例新的贲门失弛缓症病例。台湾地区的年平均发病率为每10万人1.64例(95%置信区间,1.22 - 2.05)。患者诊断时的平均年龄为51.8岁。贲门失弛缓症的年龄别发病率在70至80岁及80岁以上患者中达到峰值。对于贲门失弛缓症的诊断,分别有123例(59.71%)、97例(47.09%)、49例(23.79%)和11例(5.34%)患者进行了内镜检查、计算机断层扫描(CT)、钡餐检查和食管测压。在长期随访期间,7例患者(3.39%)发生了食管癌,39例患者(18.93%)死亡。贲门失弛缓症诊断后的中位生存期为10.65年,10年生存率为76.22%。
这是台湾地区第一项基于人群的贲门失弛缓症流行病学研究,揭示了高分辨率食管测压时代之前贲门失弛缓症的发病率。临床医生在长期随访期间应警惕食管癌的发生和死亡率。在贲门失弛缓症各种诊断工具的利用方面也有提升空间。